Literature DB >> 12741734

Coagulase-negative staphylococcal bacteremia in critically ill children: risk factors and antimicrobial susceptibility.

Shi-Ying Huang1, Ren-Bin Tang, Shu-Jen Chen, Ruey-Lung Chung.   

Abstract

Coagulase-negative staphylococci (CoNS) are the most common microorganisms isolated from blood cultures in childern, and determining whether there is true bacteremia or merely contamination is a clinical dilemma. A total of 67 episodes of CoNS-positive blood cultures in pediatric and neonatal intensive care units were evaluated during a 3-year period in order to find the possible risk factors involved and the antimicrobial susceptibility of CoNS isolates. In this study, 37 episodes were judged to be infections as opposed to 30 that were not. In comparison with individuals without infection, patients with true infection of CoNS stayed longer in the hospital (32 +/- 32.9 vs 10.7 +/- 9.3 days, p = 0.001), had more surgical procedures (32.4% vs 6.7%, p = 0.014), received more antibiotic treatments in the recent 2 weeks (37.8% vs 0%, p < 0.001), underwent more central venous catheter insertions (86.4% vs 10%, p < 0.001), received more parenteral nutrition (37.8% vs 3.3%, p = 0.001), had higher C-reactive protein profiles (4.8 +/- 5.4 vs 0.6 +/- 0.9 mg/dL, p < 0.001), and had higher neutrophil proportion (58.1% vs 44.3%, p = 0.001). However, there were no significant differences in corticosteroid therapy, hemoglobin level, total leukocyte count, and platelet count. All strains of the infection group were resistant to cefazolin, cefotaxime, penicillin, and erythromycin. Nonetheless, all isolates were susceptible to vancomycin. The percentage of multiple-resistant CoNS in the infection group was 96.9%. Empirical therapy with vancomycin for CoNS bacteremia in critically ill children is therefore recommended.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12741734

Source DB:  PubMed          Journal:  J Microbiol Immunol Infect        ISSN: 1684-1182            Impact factor:   4.399


  7 in total

1.  A quantitative analysis of Ureaplasma urealyticum and Ureaplasma parvum compared with host immune response in preterm neonates at risk of developing bronchopulmonary dysplasia.

Authors:  Matthew S Payne; Kevin C W Goss; Gary J Connett; Julian P Legg; Ken D Bruce; Vicki Chalker
Journal:  J Clin Microbiol       Date:  2011-12-21       Impact factor: 5.948

2.  Bacterial Isolates and Antibiotic Sensitivity among Gambian Children with Severe Acute Malnutrition.

Authors:  Uduak A Okomo; Danlami Garba; Augustin E Fombah; Ousman Secka; Usman N A Ikumapayi; Jacob J Udo; Martin O C Ota
Journal:  Int J Pediatr       Date:  2011-07-14

3.  Methicillin Resistant Staphylococci: Prevalence and susceptibility patterns in a burn center in Ahvaz from 2013-2014.

Authors:  Alireza Ekrami; Effat Abbasi Montazeri; Gholam Abbas Kaydani; Leili Shokoohizadeh
Journal:  Iran J Microbiol       Date:  2015-08

4.  Should first-line empiric treatment strategies cover coagulase-negative staphylococcal infections in severely malnourished or HIV-infected children in Kenya?

Authors:  Christina W Obiero; Anna C Seale; Kelsey Jones; Moses Ngari; Charlotte L Bendon; Susan Morpeth; Shebe Mohammed; Neema Mturi; Greg Fegan; James A Berkley
Journal:  PLoS One       Date:  2017-08-07       Impact factor: 3.240

5.  A Sterile Collection Bundle Intervention Reduces the Recovery of Bacteria from Neonatal Blood Culture.

Authors:  Linze F Hamilton; Helen E Gillett; Adam Smith-Collins; Jonathan W Davis
Journal:  Biomed Hub       Date:  2018-02-24

6.  Antimicrobial activity of some sulfonamide derivatives on clinical isolates of Staphylococus aureus.

Authors:  Yeliz Genç; Reşit Ozkanca; Yunus Bekdemir
Journal:  Ann Clin Microbiol Antimicrob       Date:  2008-08-20       Impact factor: 3.944

7.  Prevalence and antimicrobial susceptibility pattern of coagulase-negative staphylococci (CoNS) isolated from clinical specimens in Northern of Jordan.

Authors:  Ibrahim Ali Al Tayyar; Mazhar Salim Al-Zoubi; Emad Hussein; Salih Khudairat; Konrad Sarosiekf
Journal:  Iran J Microbiol       Date:  2015-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.